These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24051205)

  • 21. Toll-like receptors in inflammation of the central nervous system.
    Kong Y; Le Y
    Int Immunopharmacol; 2011 Oct; 11(10):1407-14. PubMed ID: 21600311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Toll-like receptors in microbiota-associated gastrointestinal cancer metastasis.
    Lu Q; Ding H; Li W
    J Cancer Res Ther; 2013 Nov; 9 Suppl():S142-9. PubMed ID: 24516050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toll-like receptors and immune regulation: implications for cancer therapy.
    Wang RF; Miyahara Y; Wang HY
    Oncogene; 2008 Jan; 27(2):181-9. PubMed ID: 18176599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Toll-like receptor-driven innate immunity in thoracic organ transplantation.
    Goldstein DR; Palmer SM
    J Heart Lung Transplant; 2005 Nov; 24(11):1721-9. PubMed ID: 16297771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of B-cell responses by Toll-like receptors.
    Pasare C; Medzhitov R
    Nature; 2005 Nov; 438(7066):364-8. PubMed ID: 16292312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toll-like receptors and innate immunity.
    Kumar H; Kawai T; Akira S
    Biochem Biophys Res Commun; 2009 Oct; 388(4):621-5. PubMed ID: 19686699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triggering of toll-like receptor signaling pathways in T cells contributes to the anti-tumor efficacy of T cell responses.
    Salem ML
    Immunol Lett; 2011 Jun; 137(1-2):9-14. PubMed ID: 21352854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surface cell markers in human lymphoid malignancies.
    Seligmann M; Preud'homme JL; Brouet JC
    Recent Results Cancer Res; 1976; (56):91-7. PubMed ID: 1087446
    [No Abstract]   [Full Text] [Related]  

  • 29. Cellular differentiation markers in lymphoproliferative diseases.
    Siegal FP
    Hosp Pract; 1978 Oct; 13(10):79-89. PubMed ID: 310413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toll-like receptors and their role in gastrointestinal disease.
    Testro AG; Visvanathan K
    J Gastroenterol Hepatol; 2009 Jun; 24(6):943-54. PubMed ID: 19638078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic and therapeutic implications of toll-like receptor ligands.
    Hedayat M; Takeda K; Rezaei N
    Med Res Rev; 2012 Mar; 32(2):294-325. PubMed ID: 22383179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphotoxin beta expression is high in chronic lymphocytic leukemia but low in small lymphocytic lymphoma: a quantitative real-time reverse transcriptase polymerase chain reaction analysis.
    Nagy B; Ferrer A; Larramendy ML; Galimberti S; Aalto Y; Casas S; Vilpo J; Ruutu T; Vettenranta K; Franssila K; Knuutila S
    Haematologica; 2003 Jun; 88(6):654-8. PubMed ID: 12801841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toll-like receptor control of the adaptive immune responses.
    Iwasaki A; Medzhitov R
    Nat Immunol; 2004 Oct; 5(10):987-95. PubMed ID: 15454922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The critical role of toll-like receptors--From microbial recognition to autoimmunity: A comprehensive review.
    Jiménez-Dalmaroni MJ; Gerswhin ME; Adamopoulos IE
    Autoimmun Rev; 2016 Jan; 15(1):1-8. PubMed ID: 26299984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toll-like receptors in the pathogenesis of human B cell malignancies.
    Isaza-Correa JM; Liang Z; van den Berg A; Diepstra A; Visser L
    J Hematol Oncol; 2014 Aug; 7():57. PubMed ID: 25112836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TLR signaling by tumor and immune cells: a double-edged sword.
    Huang B; Zhao J; Unkeless JC; Feng ZH; Xiong H
    Oncogene; 2008 Jan; 27(2):218-24. PubMed ID: 18176603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toll-like receptors signaling: A complex network for NF-κB activation in B-cell lymphoid malignancies.
    Ntoufa S; Vilia MG; Stamatopoulos K; Ghia P; Muzio M
    Semin Cancer Biol; 2016 Aug; 39():15-25. PubMed ID: 27402288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of Toll-like receptor signaling pathways in innate immune responses.
    Qian C; Cao X
    Ann N Y Acad Sci; 2013 Apr; 1283():67-74. PubMed ID: 23163321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Volume regulation in leukemic and lymphoma cells in children and determination of cell lineage.
    Yumura K; Kawa-Ha K; Hara J; Franco EP; Ishihara S; Doi S; Yabuuchi H
    Jpn J Cancer Res; 1986 Apr; 77(4):392-8. PubMed ID: 3084429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential immune effects mediated by Toll-like receptors stimulation in precursor B-cell acute lymphoblastic leukaemia.
    Corthals SL; Wynne K; She K; Shimizu H; Curman D; Garbutt K; Reid GS
    Br J Haematol; 2006 Feb; 132(4):452-8. PubMed ID: 16412017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.